POP Biotechnologies

Dedicated to the development and commercialization of safer, more effective cancer treatments harnessing photosensitive nanoparticles.

[POP Biotechnologies @popbiotech]

POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP™ https://t.co/lOTrCgNGQW

[POP Biotechnologies @popbiotech]

POP BIO announces findings for an Alzheimer’s Disease polyvalent peptide immunotherapy https://t.co/z6NH5j4qmE via @ein_news

[POP Biotechnologies @popbiotech]

POP BIO announces collaboration with Funpep for antibody inducing peptide therapy https://t.co/sucq2mcYnw

[POP Biotechnologies @popbiotech]

POP BIO and EuBiologics’ Shingles Vaccine Enters Phase 1 Clinical Trials https://t.co/nEMnEaDXGm

[POP Biotechnologies @popbiotech]

POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19 https://t.co/5udTWZB1M5

[POP Biotechnologies @popbiotech]

POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as Part of Eubiologics' COVID-19 Va ... https://t.co/rp114RzwpK

[UBuffalo Engineering and Applied Sciences @UBengineering]

We're told by #Buffalo prof. and @popbiotech co-founder Jon Lovell that clinical trials for this WNY co-developed COVID vaccine has begun!! https://t.co/V6yTHiWWz2

[POP Biotechnologies @popbiotech]

POP BIO recieves $3M equity investment paired with formation of Joint Venture to combat RSV, Alzheimer's https://t.co/3enDiiDK7d

[Buffalo Business First @BfloBizFirst]

“It’s been a super exciting year with one positive development after another,” said @PopBiotech co-founder Jonathan Smyth as it moves closer to putting its vaccine development platform to good use.

READ MORE: https://t.co/bPioHTP7jT

#healthcare #startups #Buffalo #NewYork #WNY

[POP Biotechnologies @popbiotech]

POP BIO enters $3M eqity imvestment and JV agreement with Eubiologics https://t.co/3enDiiDK7d

[UBuffalo @UBuffalo]

Fighting #HIV 💪🏽 A more effective vaccine to stop the #AIDS-causing virus is being developed by #UBuffalo spinoff @popbiotech! @UBScience https://t.co/krCeySIQOe

[POP Biotechnologies @popbiotech]

We have some exciting news to share - we made it to the semifinals of @forty3north’s $5 million startup competition! https://t.co/GmUxHhr03J #itshappeninghere

[POP Biotechnologies @popbiotech]

POP BIO Announces $600K Contract Award from NIH, supporting
the development of a novel HIV envelope trimer vaccine, with Scripps Research Institute https://t.co/3KAjNYDkw8

[Upstate Venture Connect @UVConnect]

#Buffalo startups to watch! @Carteficom @theXplatform @popBiotech - Members of the @wnyINCUBATORS' Student Sandbox program.

[Buffalo Business First @BfloBizFirst]

.@popbiotech impressed @SteveCase when @RiseOfRest came to #Buffalo, @BfloBiz_Miner speaks to POPbio's @jflovell https://t.co/kEuj8Bmtnz

[Buffalo Business First @BfloBizFirst]

.@popbiotech will further develop a nano balloon that safely delivers cancer treatments directly to solid tumors https://t.co/rvFmiD9YIR

[SelectOne @SelectOneLLC]

@energyintel and @POPBiotech use $100K to grow their businesses http://t.co/Nb6nhCUEx5 @BfloBizFirst #RisetheRest

[Scott Patterson @ScottMPatterson]

.@AOL co-founder @SteveCase among judges to award $100,000 each to @EnergyIntellig & @popbiotech. https://t.co/sZ5HXyjebn

[POP Biotechnologies @popbiotech]

.@popbiotech @jr_smyth and @jflovell enthusiastically accepting our $100K award at the #Buffalo @RiseOfRest

[SelectOne @SelectOneLLC]

Nothing new for @popbiotech as they captivate the audience once again. #RisetheRest @SteveCase